Daewoong Achieves Import of Its BT-Based Treatment, Easyef, to Middle East Market

Published: 2004-12-21 06:55:00

Updated: 2004-12-21 06:55:00

Daewoong Pharmaceutical announced on December 17th that the company’s next-generation drug, Easyef, has received a marketing permission from Jordan, providing an entry to the Middle East market starting Year 2005.

Daewoong’s Easyef, a spray-type external preparation, is for treatment of diabe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK